Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...

Full description

Bibliographic Details
Main Authors: Jonathon R. Campbell, Dennis Falzon, Fuad Mirzayev, Ernesto Jaramillo, Giovanni Battista Migliori, Carole D. Mitnick, Norbert Ndjeka, Dick Menzies
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-03-01
Series:Emerging Infectious Diseases
Subjects:
tuberculosis
multidrug resistance
therapy data collection
data collection standards
meta-analysis
evidence-based medicine
Online Access:https://wwwnc.cdc.gov/eid/article/26/3/19-0997_article

Internet

https://wwwnc.cdc.gov/eid/article/26/3/19-0997_article

Similar Items